AR034920A1 - METHODS FOR THE TREATMENT OF INFLAMMATORY INTESTINAL DISEASES - Google Patents

METHODS FOR THE TREATMENT OF INFLAMMATORY INTESTINAL DISEASES

Info

Publication number
AR034920A1
AR034920A1 ARP020102846A ARP020102846A AR034920A1 AR 034920 A1 AR034920 A1 AR 034920A1 AR P020102846 A ARP020102846 A AR P020102846A AR P020102846 A ARP020102846 A AR P020102846A AR 034920 A1 AR034920 A1 AR 034920A1
Authority
AR
Argentina
Prior art keywords
treatment
methods
intestinal diseases
inflammatory intestinal
inflammatory
Prior art date
Application number
ARP020102846A
Other languages
Spanish (es)
Inventor
Simone Claudio De
Original Assignee
Simone Claudio De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simone Claudio De filed Critical Simone Claudio De
Publication of AR034920A1 publication Critical patent/AR034920A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Las condiciones inflamatorias en la mucosa intestinal se previenen o tratan con una composición probiótica farmacéutica o dietaria que contiene Streptococci, Lactobacilli y Bifidobacteria protectores en una cantidad diaria de 10 a 3.600 x 10(9) células bacterianas.Inflammatory conditions in the intestinal mucosa are prevented or treated with a pharmaceutical or dietary probiotic composition containing protective Streptococci, Lactobacilli and Bifidobacteria in a daily amount of 10 to 3,600 x 10 (9) bacterial cells.

ARP020102846A 2001-07-30 2002-07-29 METHODS FOR THE TREATMENT OF INFLAMMATORY INTESTINAL DISEASES AR034920A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30811701P 2001-07-30 2001-07-30

Publications (1)

Publication Number Publication Date
AR034920A1 true AR034920A1 (en) 2004-03-24

Family

ID=23192625

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020102846A AR034920A1 (en) 2001-07-30 2002-07-29 METHODS FOR THE TREATMENT OF INFLAMMATORY INTESTINAL DISEASES

Country Status (3)

Country Link
AR (1) AR034920A1 (en)
AU (1) AU2002329043A1 (en)
WO (1) WO2003013558A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481681A1 (en) * 2003-05-30 2004-12-01 Claudio De Simone Lactic acid bacteria combination and compositions thereof
FR2875406B1 (en) * 2004-09-21 2007-01-05 Danisco STRAIN OF LACTOBACILLUS ACIDOPHILUS HAVING ANALGESIC PROPERTIES AT THE GASTROINTESTINAL SYSTEM LEVEL
WO2008064521A1 (en) * 2006-11-30 2008-06-05 Pharmapep Research & Development (Shenzhen) Co., Ltd. Lactobacillus fermentum cms-h002 and use thereof
JP5203393B2 (en) * 2008-01-15 2013-06-05 サッポロビール株式会社 Alcoholic liver injury inhibitor
FI20096400A0 (en) * 2009-12-28 2009-12-28 Suomen Punainen Risti Veripalv Use of blood group status I
EP2228067B1 (en) * 2010-02-22 2013-12-11 LR Health & Beauty Systems GmbH Probiotic compound and use of same
KR101916853B1 (en) * 2010-07-26 2018-11-09 큐 바이올로직스 인코포레이티드 Immunogenic anti-inflammatory compositions
CN104398538A (en) * 2014-10-28 2015-03-11 大连医科大学 Composite probiotics preparation for mitigating chemotherapy side effect
CN110023484B (en) * 2016-12-20 2022-11-08 深圳华大生命科学研究院 Bifidobacterium pseudocatenulatum as well as culture method and application thereof
WO2019227414A1 (en) * 2018-05-31 2019-12-05 深圳华大生命科学研究院 Composition and uses thereof
CN111248443A (en) * 2020-03-10 2020-06-09 安徽大学 Synbiotic composition capable of improving ulcerative colitis and preparation and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
IT1307850B1 (en) * 1999-03-15 2001-11-19 Italmed Di Galli Giovanna E Pa PHARMACEUTICAL COMPOSITION BASED ON LACTIC FERMENTS AND NON-ABSORBABLE CARBOHYDRATIN CONTAINING A CALCIUM SALT AND AN ALUMINUM SALT

Also Published As

Publication number Publication date
WO2003013558A1 (en) 2003-02-20
WO2003013558A8 (en) 2003-08-14
AU2002329043A1 (en) 2003-02-24

Similar Documents

Publication Publication Date Title
BR0213189A (en) Composition comprising a lactobacillus pentosus strain and uses thereof
CO5160320A1 (en) METHODS AND COMPOSITIONS FOR THE PREVENTION OF TOLERANCE TO MEDICINES DAS.
BR9916062A (en) Oral administration of lactobacillus for the treatment and prevention of urogenital infection
BRPI0615785B8 (en) cholesterol absorption inhibitor composition comprising bacteria of the bifidobacterium genus
BR9910251A (en) Hematopoietic stimulation
WO2002083879A3 (en) Immunotherapy based on dendritic cells
DE69905368D1 (en) Oxydiertes thymosin beta 4
BR9811825A (en) Use of lactobacillus to reduce the level of fibrinogen in the blood
AR034920A1 (en) METHODS FOR THE TREATMENT OF INFLAMMATORY INTESTINAL DISEASES
EP1393734A4 (en) Drugs for intestinal diseases
NO985980D0 (en) Lectin preparations and uses thereof
ATE221783T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LACTOBACILLUS PLANTARUM AND ARGININE
HUP0201631A2 (en) Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
BRPI0409609A (en) reverse cholesterol transport mediators for the treatment of hypercholesterolemia
AU5634500A (en) Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis
ATE333875T1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING SOYAI SOFLAVONE EXTRACTS AND PROBIOTIC MICROORGANISMS
EE05412B1 (en) Method for screening probiotic strains of the Bifidobacterium family
WO2003080568A3 (en) Probucol derivatives
BRPI0411436A (en) composition, dietary supplement, pharmaceutical composition, and, methods of treatment for liver cancer, for chemo-damage to the liver, and a hepatobiliary system disorder, and for cirrhosis and liver hepatitis
ATE435595T1 (en) TABLE OLIVES CONTAINING PROBIOTIC MICROORGANISMS
DK1212072T3 (en) Pharmaceutical composition comprising eucalyptus and orange oil
IT1274733B (en) Strain of the genus Lactobacillus of human origin and its uses
GEP20002176B (en) Ointment “Bentastatin” for Treatment of Fungus Diseases of Skin and Mucous Membrane and Inflammatory Processes
MD20010055A (en) Microbial sanogenic preparation for prevention and treatment of intestinal disbacteriosis

Legal Events

Date Code Title Description
FA Abandonment or withdrawal